Pyogenic Granuloma is a benign (non-cancerous) blood vessel tumor that develops on the surface of the skin. It can also develop on mucous membranes, capillaries (small blood vessels), and other parts of the body. These growths can appear after an injury, but the cause is unknown.
Other causes of pyogenic granulomas include damage from insect bites or scratching your skin harshly or regularly.
The hormone changes your body goes through during pregnancy can also cause pyogenic granulomas.
Nonmedical treatment of pyogenic granulomas (PGs) most commonly consists of shave removal and electrocautery or surgical excision with primary closure.
Laser therapy has been recently advanced as a more developed technology treatment that is perceived to mild Pyogenic Granuloma-surgery pains.
The Portable Surgery Laser System FDA LASER-1.2A System is a professional device that promotes laser treatment.
The tissue components hemoglobin and melanin interact more with the blue laser light even at reduced power. Accordingly, This allows LASER-1.2A to perform better and softer cutting at 810 nm.
As a result of its increased cutting capability, the device is suitable for all medical applications and scrapping.
What also makes the LASER-1.2A highly recommended by surgeons is that it displays an accurate alignment and exact sighting during the treatment. All thanks to its green aiming beam.
To further improve the treatment, the device is supported with a fiber guide laser. First, it is compatible with various endoscopic uses. Second, these special fibers are sterilizable which, in turn, prevents any possible cross-infection while guaranteeing a clean and bloodless operative area.
This is due in large part to the fact that the LASER-1.2 A employs infrared wavelengths and ultra-blue light to assure peak performance. This really minimizes heat damage as well as its unusual interaction with hemoglobin.
Thanks to all these features and more, the LASER-1.2A guarantees increased cutting effectiveness, much higher than the one obtained with infrared lasers.
Furthermore, the complete lack of water absorption significantly reduces the warming of the surrounding tissues. This should increase the efficacy of the laser therapy.
Lasers are a relatively new adjunct to the treatment of Pyogenic Granuloma. Laser use and applications have grown dramatically since their creation. In this essay, we will explore the advantages of laser therapy and, more specifically, the efficacy of LASER-1.2 A as a surgical laser device for eradicating dissecting Granuloma tumors.
Reference: What Is a Pyogenic Granuloma? , Endoscopic laser therapy in gastroenterology.
Disclaimer: Although the information we provide is used by different doctors and medical staff to perform their procedures and clinical applications, the information contained in this article is for consideration only. SIFLASER is not responsible neither for the misuse of the device nor for the wrong or random generalizability of the device in all clinical applications or procedures mentioned in our articles. Users must have the proper training and skills to perform the procedure with each Laser System.
The products mentioned in this article are only for sale to medical staff (doctors, nurses, certified practitioners, etc.) or to private users assisted by or under the supervision of a medical professional.